Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

Mosapride in the Treatment of Gastrointestinal Disorders

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2010:2

Review

Published on 16 Mar 2010

DOI: 10.4137/CMRT.S1600


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

Prokinetic drugs are being used with increasing frequency in the treatment of functional gastrointestinal disorders including functional dyspepsia (FD) and constipation-predominant Irritable Bowel Syndrome (IBS-C). Mosapride is a gastro-prokinetic agent that acts as a selective 5-HT4 agonist thereby accelerating gastric emptying. It has been used for the treatment of irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroesophageal reflux (GERD). Mosapride shares physiologic effects with previous 5-HT4 agonists, cisapride and tegaserod, but with a safer cardiac profile.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Libertas Academica
Clinical Medicine Insights: Case Reports was very thorough. I appreciated the way you painstakingly followed all the processes of verifying submitted manuscripts for publication.  It shows that you do not just allow anything to pass for publication!  Please keep the good work. Science and indeed biological research should be verifiable and dynamic.
Dr Ali Ishaq Shugaba (University of Jos, Nigeria)
More Testimonials

Quick Links


New article and journal news notification services